Verseon has assembled a talented team of scientists and engineers with expertise in physics, mathematics, medicinal and synthetic chemistry, biology, computer science, and early-stage drug discovery.

Senior team members are: 

Adityo Prakash, Founder, CEO: Experienced in bringing breakthrough technologies to market; co-founder and former CEO of Pulsent Corp.; inventor on 35 patents; BS, California Institute of Technology

Eniko Fodor, Founder, COO : Experienced in building cutting-edge technology organizations with highly effective operating, marketing, and IP strategies; co-founder and former COO of Pulsent Corp.; inventor on 17 patents; BS, Universitatea Babes-Bolyai, Romania 

David Kita, Founder, Vice President R&D: Experienced in developing technological solutions in molecular modeling, bioinformatics, and signal processing; former Director of R&D of Pulsent Corp. and Director of Software and Algorithm Development – Bioinformatics at Hyseq Inc; inventor on 16 patents; Ph.D., University of Wisconsin, Madison

Kevin Short, Director, Discovery Programs: Experienced in drug discovery planning, program evaluation, and business development; led discovery programs at Johnson & Johnson and managed multiple drug programs at Ontogen Corp.; inventor on 12 patents; Ph.D., University of Exeter, UK

David Williams, Director, R&D: Experienced in running successful computational physics and chemistry programs; led large research teams in high-energy physics simulations at the Stanford Linear Accelerator Center (SLAC); Ph.D., Massachusetts Institute of Technology

Anirban Datta, Director, Discovery Biology: Experienced in cancer cell biology, biochemistry, and novel bio-assay development; elucidated signaling in cancer metastasis at UCSF; co-founded and led development of 3-D cell-culture assays at Pharmacomatrix Inc.; Ph.D., University of Pennsylvania